Katsuki Tsuritani

1.1k total citations
19 papers, 474 citations indexed

About

Katsuki Tsuritani is a scholar working on Oncology, Immunology and Molecular Biology. According to data from OpenAlex, Katsuki Tsuritani has authored 19 papers receiving a total of 474 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Oncology, 6 papers in Immunology and 5 papers in Molecular Biology. Recurrent topics in Katsuki Tsuritani's work include Psoriasis: Treatment and Pathogenesis (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Katsuki Tsuritani is often cited by papers focused on Psoriasis: Treatment and Pathogenesis (4 papers), Rheumatoid Arthritis Research and Therapies (4 papers) and Lymphoma Diagnosis and Treatment (3 papers). Katsuki Tsuritani collaborates with scholars based in Japan, United States and United Kingdom. Katsuki Tsuritani's co-authors include Yusuke Kuwahara, Kiyofumi Yamada, Yukio Yoneda, Hiroyuki Kamei, Hiroyuki Mizoguchi, Toshitaka Nabeshima, Hiroyuki Koike, Kazuhiro Takuma, Taku Nagai and Daisuke Ibi and has published in prestigious journals such as Journal of Biological Chemistry, Biochemical Journal and Brain Research.

In The Last Decade

Katsuki Tsuritani

16 papers receiving 468 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Katsuki Tsuritani Japan 9 136 81 80 66 62 19 474
Chun‐Sheng Ruan Australia 12 122 0.9× 97 1.2× 173 2.2× 51 0.8× 48 0.8× 13 482
Kitty Reemst Netherlands 8 112 0.8× 71 0.9× 80 1.0× 87 1.3× 30 0.5× 9 537
Xuebo Yan China 12 228 1.7× 54 0.7× 133 1.7× 42 0.6× 23 0.4× 28 557
Miklós Sárvári Hungary 15 202 1.5× 123 1.5× 83 1.0× 106 1.6× 48 0.8× 27 658
Alexis M. Ceasrine United States 11 145 1.1× 47 0.6× 50 0.6× 83 1.3× 25 0.4× 14 509
Cécile Allet France 10 168 1.2× 47 0.6× 114 1.4× 30 0.5× 51 0.8× 13 601
Chunrui Yang China 13 147 1.1× 109 1.3× 170 2.1× 24 0.4× 48 0.8× 19 465
Qi-Gang Zhou China 6 245 1.8× 60 0.7× 50 0.6× 32 0.5× 22 0.4× 7 504
Cynthia Vied United States 15 349 2.6× 39 0.5× 116 1.4× 70 1.1× 33 0.5× 31 642

Countries citing papers authored by Katsuki Tsuritani

Since Specialization
Citations

This map shows the geographic impact of Katsuki Tsuritani's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Katsuki Tsuritani with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Katsuki Tsuritani more than expected).

Fields of papers citing papers by Katsuki Tsuritani

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Katsuki Tsuritani. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Katsuki Tsuritani. The network helps show where Katsuki Tsuritani may publish in the future.

Co-authorship network of co-authors of Katsuki Tsuritani

This figure shows the co-authorship network connecting the top 25 collaborators of Katsuki Tsuritani. A scholar is included among the top collaborators of Katsuki Tsuritani based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Katsuki Tsuritani. Katsuki Tsuritani is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
2.
Morita, Akimichi, Shinichi Imafuku, Yayoi Tada, et al.. (2025). Deucravacitinib in plaque psoriasis: Safety and efficacy through 3 years in Japanese patients in the phase 3 POETYK PSO ‐1, PSO ‐4, and LTE trials. The Journal of Dermatology. 52(5). 761–772. 1 indexed citations
4.
Tada, Yayoi, et al.. (2023). Treatment patterns of systemic drug use in Japanese patients with plaque psoriasis: A retrospective chart review. The Journal of Dermatology. 51(2). 210–222. 4 indexed citations
7.
Harigai, Masayoshi, et al.. (2021). Long-term safety and effectiveness of abatacept in Japanese patients with rheumatoid arthritis: 3-year follow-up of a postmarketing surveillance. Modern Rheumatology. 32(3). 508–516. 5 indexed citations
8.
Tanaka, Eiichi, et al.. (2021). POS0603 ANALYSIS OF FACTORS ASSOCIATED WITH THE EFFECTIVENESS OF ABATACEPT IN THE ORIGAMI STUDY. Annals of the Rheumatic Diseases. 80. 536–536. 1 indexed citations
9.
Nakao, Toru, Katsuki Tsuritani, Takashi Yamada, et al.. (2020). The importance of specific citrullinated clusterin and vimentin found in a multi-coloured bead-based citrulline-peptide array system in rheumatoid arthritis. Clinical and Experimental Rheumatology. 40(5). 936–944. 4 indexed citations
10.
Tsuji, Satoshi, Yusuke Kuwahara, Hironori Takagi, et al.. (2015). Gene expression analysis in the lung of the rasH2 transgenic mouse at week 4 prior to induction of malignant tumor formation by urethane and N-methylolacrylamide. The Journal of Toxicological Sciences. 40(6). 685–700. 3 indexed citations
11.
Tsuritani, Katsuki, Junko Takeda, Junko Sakagami, et al.. (2009). Cytokine Receptor-Like Factor 1 is Highly Expressed in Damaged Human Knee Osteoarthritic Cartilage and Involved in Osteoarthritis Downstream of TGF-β. Calcified Tissue International. 86(1). 47–57. 28 indexed citations
12.
Tsuritani, Katsuki, Takanobu Sakurai, Kikuya Kato, et al.. (2009). Transcriptional induction and translational inhibition of Arc and Cugbp2 in mice hippocampus after transient global ischemia under normothermic condition. Brain Research. 1287. 136–145. 9 indexed citations
13.
Sakai, Takayuki, et al.. (2009). Effects of kynurenine metabolites on mesangial cell proliferation and gene expression. Experimental and Molecular Pathology. 87(1). 70–75. 25 indexed citations
14.
Kuwahara, Yusuke, et al.. (2008). Downregulated expression in high IgA (HIGA) mice and the renal protective role of meprinβ. Life Sciences. 82(15-16). 899–908. 6 indexed citations
15.
Ibi, Daisuke, Kazuhiro Takuma, Hiroyuki Koike, et al.. (2007). Social isolation rearing‐induced impairment of the hippocampal neurogenesis is associated with deficits in spatial memory and emotion‐related behaviors in juvenile mice. Journal of Neurochemistry. 105(3). 921–932. 199 indexed citations
16.
Tsuritani, Katsuki, Takuma Irie, Riu Yamashita, et al.. (2007). Distinct class of putative “non-conserved” promoters in humans: Comparative studies of alternative promoters of human and mouse genes. Genome Research. 17(7). 1005–1014. 28 indexed citations
17.
Nakagawa, Junichi, Tomoya Isaji, Noriyuki Usami, et al.. (2002). Molecular Characterization of Mammalian Dicarbonyl/l-Xylulose Reductase and Its Localization in Kidney. Journal of Biological Chemistry. 277(20). 17883–17891. 87 indexed citations
18.
Fujii, Yasuyuki, Toru Nakao, Katsuki Tsuritani, et al.. (2001). GENE EXPRESSION PROFILES FOR FcϵRI, CYTOKINES AND CHEMOKINES UPON FcϵRI ACTIVATION IN HUMAN CULTURED MAST CELLS DERIVED FROM PERIPHERAL BLOOD. Cytokine. 16(4). 143–152. 28 indexed citations
19.
Aoki, Mari, Katsuki Tsuritani, Kenji Hiura, et al.. (1997). Chick osteocyte-derived protein inhibits osteoclastic bone resorption. Biochemical Journal. 322(1). 245–250. 30 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026